Apellis Pharmaceuticals, Inc.
(NASDAQ : APLS)

( )
APLS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.12%182.300.7%$1409.86m
MRKMerck & Co., Inc. -0.51%92.800.7%$1235.13m
PFEPfizer Inc. 0.04%51.720.9%$1234.67m
LLYEli Lilly & Co. 0.03%325.801.1%$1136.42m
BMYBristol-Myers Squibb Co. -0.17%78.861.0%$1135.54m
ABBVAbbVie, Inc. 0.22%152.881.9%$1021.46m
AZNAstraZeneca Plc -0.84%66.341.0%$448.31m
SGENSeagen Inc. -1.61%176.455.7%$320.77m
GSKGSK Plc -0.62%43.420.2%$295.60m
TPTXTurning Point Therapeutics, Inc. 0.00%75.170.0%$291.93m
MRTXMirati Therapeutics, Inc. 2.70%70.001.6%$204.79m
SIGASIGA Technologies, Inc. -10.51%11.670.0%$196.60m
HZNPHorizon Therapeutics Plc 0.00%85.135.4%$182.59m
NVSNovartis AG 0.07%84.880.2%$167.87m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.15%144.000.0%$147.86m

Company Profile

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic and complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.